Immune markers in salivary gland cancer
Part of Cancer, Mouth & dental clinical trials.
This study looks at immune cells and substances in blood, saliva, and stool from people with salivary gland cancer. The goal is to find markers that could help predict how the disease behaves.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You have been newly diagnosed with a type of salivary gland cancer (not squamous cell carcinoma).
- Your tumor must be large enough to allow a small sample to be taken without affecting the pathology results.
- You are willing to provide blood, saliva, and stool samples.
- You have no other cancer (except certain skin cancers) in the last 5 years and no spread of your current cancer to distant organs.
- You do not have drug or alcohol abuse, or a language barrier that would prevent understanding the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses special MRI scans to learn how salivary gland tumors work in the body. It may help improve diagnosis and how tumors are evaluated without needing treatment yet.
This study looks at “immune signals” in blood, saliva, and stool to learn more about head and neck cancers (especially squamous cell carcinoma). It may help researchers find patterns that improve understanding of disease or how treatment should be guided.
This trial studies the genetic activity (gene expression) in tumor tissue from people with salivary gland cancer. It aims to improve understanding of these cancers and may help guide future treatment decisions.
This study looks at certain genes and proteins in the saliva of people with oral cavity cancer. It aims to find markers that might help with diagnosis or treatment planning, before any cancer therapy has started.
This study looks at diseases that involve the salivary (saliva) glands, and may also include people with active hepatitis, oral cancer, or healthy adults. Researchers collect blood, urine, saliva, and sometimes tissue to better understand what’s happening and how these conditions relate to saliva and oral health.
This study looks for changes in saliva (epigenetic biomarkers) that may help doctors diagnose squamous cell carcinoma in the mouth. You may be asked for saliva samples and usual clinical checks to see whether the test can help with diagnosis, especially before surgery.
Hear when a new Salivary Gland Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.